Eurobio Scientific: agreement with Myriad Genetics
Following this acquisition, Eurobio Scientific will grant Myriad Genetics a license to manufacture, sell and distribute the EndoPredict breast cancer screening test for laboratory developed tests (LDT), mainly in the United States.
In addition, Myriad Genetics will grant Eurobio Scientific a license to manufacture, sell and distribute the Prolaris prostate cancer screening test kit. Completion of the transaction is scheduled for next July.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction